Padraic G. Fallon

Active 1994–2025

123
Papers
25,179
Citations
84
h-index
121
i10-index

Citations

Citations per year for Padraic G. Fallon1992: 1 citations1995: 2 citations1996: 6 citations1997: 7 citations1998: 9 citations1999: 19 citations2000: 65 citations2001: 81 citations2002: 62 citations2003: 64 citations2004: 97 citations2005: 55 citations2006: 83 citations2007: 101 citations2008: 119 citations2009: 122 citations2010: 177 citations2011: 220 citations2012: 284 citations2013: 319 citations2014: 385 citations2015: 486 citations2016: 420 citations2017: 504 citations2018: 443 citations2019: 1,199 citations2020: 1,232 citations2021: 1,208 citations2022: 980 citations2023: 794 citations2024: 1,116 citations2025: 578 citations2026: 6 citations1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,256 citing papers, 24.5% of this breakdownChina: 1,796 citing papers, 13.5% of this breakdownUnited Kingdom: 1,213 citing papers, 9.1% of this breakdownGermany: 832 citing papers, 6.3% of this breakdownJapan: 528 citing papers, 4% of this breakdownFrance: 479 citing papers, 3.6% of this breakdownCanada: 408 citing papers, 3.1% of this breakdownAustralia: 394 citing papers, 3% of this breakdownItaly: 369 citing papers, 2.8% of this breakdownIreland: 342 citing papers, 2.6% of this breakdownSwitzerland: 337 citing papers, 2.5% of this breakdownNetherlands: 323 citing papers, 2.4% of this breakdown
0%24.5%Other 22.6%

Fields

  • Immunology and Microbiology44.2%
  • Medicine33.2%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Neuroscience2.2%
  • Nursing0.5%
  • Agricultural and Biological Sciences0.5%
  • Other2.1%

Topics

  • IL-33, ST2, and ILC Pathways8.8%
  • Immune Cell Function and Interaction7.7%
  • Eosinophilic Esophagitis4.3%
  • Asthma and respiratory diseases4.1%
  • Dermatology and Skin Diseases3.7%
  • Immune cells in cancer3.1%
  • Other68.3%

Coauthors

All papers

Open in search
  1. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Frezza, Albena T. Dinkova‐Kostova, Richard C. Hartley, Michael P. Murphy, Luke O'neill - Nature 2018 cited by 1,905

  2. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2022 cited by 318

  3. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

    Authors: , , , , , , , , , , , - Nature 2010 cited by 2,067

  4. The alarmin IL-33 promotes regulatory T-cell function in the intestine

    Authors: , , , , , , , , , , , , , , , - Nature 2014 cited by 1,015

  5. A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 952

  6. Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment

    Authors: , , , , , , , , , , - Cancer Cell 2023 cited by 119

  7. MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion

    Authors: , , , , , , , , , , , , - Immunity 2014 cited by 682

  8. PD-L1hi B cells are critical regulators of humoral immunity

    Authors: , , , , , - Nature Communications 2015 cited by 370

  9. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells

    Authors: , , , , , , , , , , , , , , , - Immunity 2018 cited by 242

  10. Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung

    Authors: , , , , , , , , , , , , - Immunity 2016 cited by 342

  11. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses

    Authors: , , , , , , - Nature Immunology 2015 cited by 326

  12. Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM

    Authors: , , , , , , , , , , , , - Immunity 2019 cited by 144

  13. When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2022 cited by 101

  14. Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip M. Hansbro, Rachel M. McLoughlin, Małgorzata Wygrecka, Roger J. S. Preston, Zbigniew Zasłona, Luke O'neill - Nature Communications 2023 cited by 64

  15. Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 345

  16. Aging impairs peritoneal but not bone marrow‐derived macrophage phagocytosis

    Authors: , , , , , - Aging Cell 2014 cited by 175

  17. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 188

  18. SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation

    Authors: , , , , , , , , , , , , , , , , - Nature Metabolism 2021 cited by 92

  19. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 367

  20. The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses

    Authors: , , , , , , , , , , , , , , , - Science 2012 cited by 415

  21. Hypoxia-dependent regulation of inflammatory pathways in immune cells

    Authors: , , , - Journal of Clinical Investigation 2016 cited by 210

  22. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency

    Authors: , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2012 cited by 267

  23. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells

    Authors: , , , , , , , , , , , , , , , , , - Cell 2017 cited by 177

  24. IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2023 cited by 40